Interhemispheric Connectivity and Compensation
Interhemispheric Communication and Compensation in Peripheral Nerve Injury
2 other identifiers
interventional
120
1 country
1
Brief Summary
The goal of this study is to determine which parts of the brain make it possible for some people to move skillfully with their left non-dominant hand.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 9, 2021
CompletedFirst Submitted
Initial submission to the registry
December 25, 2021
CompletedFirst Posted
Study publicly available on registry
January 26, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2025
CompletedOctober 9, 2025
October 1, 2025
3.6 years
December 25, 2021
October 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
BOLD (blood oxygen level dependent) signal in ROIs (regions of interest)
BOLD signal in key ROIs (primary motor and posterior parietal cortex). ROI selection may be revisited after preliminary data review (35 participants)
Day 1
Secondary Outcomes (2)
Drawing smoothness
Day 1
Hand choice
Day 1
Study Arms (1)
Movement task
EXPERIMENTALAll participants perform the STEGA-MRI (standardized tracing evaluation \& grapheme assessment - MRI) precision drawing task during fMRI scanning. Motor assessments outside the MRI do not qualify as interventions.
Interventions
Eligibility Criteria
You may qualify if:
- Age ≥ 18
- English speaking and reading
- Able to fit in Prisma scanner bore (60 cm diameter)
- Right hand dominant (self report, and Edinburgh handedness ≥ +40)
- Chronic unilateral upper extremity peripheral nerve injury to the right side
- "Chronic" defined as ≥ 6 months since injury
- "Upper extremity" defined as hand, arm, or shoulder (including e.g. brachial plexus)
- "Injury" defined as localized cause (e.g. mechanical/tumor, not distributed pathology), including compression
- Some impairment to writing, requiring both of:
- Difficulty writing, as determined by score 2+ (Mild+) on "How much difficulty have you had in the last week with writing?" (From Disabilities of the Arm, Shoulder, and Hand survey question #2)
- Box and Blocks motor performance ≥1 standard deviation below the mean of age-matched healthy adults (Mathiowetz et al. 1985, AJOT).
You may not qualify if:
- Currently intoxicated or otherwise non-compliant
- Chronic pain diagnosis unrelated to the nerve injury
- Uncorrected visual impairment that interferes with ability to see drawings in MRI
- Motor function diagnoses that affect function of the left hand, now or in past 2 years
- Motor function diagnoses currently affecting the right hand, unrelated to the nerve injury
- This is not meant to exclude a single event with complex consequences (e.g. nerve and tendon)
- This is not meant to exclude multiple nerve injuries in the same arm, if each one is eligible (II.B.1)
- This is meant to exclude e.g. injury and unrelated musculoskeletal disorder in same arm
- Upper extremity surgery, including peripheral nerve surgery, within last 2 months
- Contraindication for MRI
- Contraindication for transcranial magnetic stimulation (TMS)
- May exclude from TMS only (since not all participants undergo TMS), or exclude from full study
- Amputation affecting any part of thumb, index, or middle fingers (including higher level, e.g. whole hand)
- History of chronic cocaine use (based on medical record or volunteered; will not actively inquire)
- Diagnosis of schizophrenia or other rare psychiatric disorder
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Washington University School of Medicine
St Louis, Missouri, 63108, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Benjamin A Philip, PhD
Washington University School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- During TMS, participants will be masked to whether they receive effective or sham stimulation on a given trial.
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 25, 2021
First Posted
January 26, 2022
Study Start
December 9, 2021
Primary Completion
August 1, 2025
Study Completion
August 1, 2025
Last Updated
October 9, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- Will become available after summary data are published. Will remain available indefinitely.
For participants who consent to us sharing their data with other researchers, we will share all anonymized data (behavioral, survey, and MRI), including data dictionaries. Note that this clinical trial is a "prospective basic science study involving human participants;" i.e., a study that falls within the NIH definition of clinical trial while also meeting the definition of basic research.